Romero, Atocha <br/><br/>
Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  Mar 2012 
 - 163-8 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-012-0779-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--therapeutic use<br/>Antigens, Neoplasm--genetics<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Pharmacological--analysis<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--diagnosis<br/>Carcinoma--diagnosis<br/>DNA Topoisomerases, Type II--genetics<br/>DNA-Binding Proteins--genetics<br/>Female<br/>Humans<br/>Models, Biological<br/>Poly-ADP-Ribose Binding Proteins<br/>Predictive Value of Tests<br/>Prognosis<br/>Treatment Outcome